JPH09506001A - 異種二重特異性抗体の製造法 - Google Patents
異種二重特異性抗体の製造法Info
- Publication number
- JPH09506001A JPH09506001A JP8500228A JP50022896A JPH09506001A JP H09506001 A JPH09506001 A JP H09506001A JP 8500228 A JP8500228 A JP 8500228A JP 50022896 A JP50022896 A JP 50022896A JP H09506001 A JPH09506001 A JP H09506001A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- subclass
- bsak
- protein
- rat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.異種二重特異性抗体を製造するための方法において、 a) 1つのハイブリドーマが、蛋白質Aの結合ドメインに対する親和性を有す る抗体(1)を生産し、この場合、抗体(1)は、マウス抗体、サブクラスIg G1、IgG2、IgG4のヒト抗体もしくはヒト化された抗体またはサブクラ スIgG2cのラット抗体であり、かつ別のハイブリドーマが、抗体(1)と比 べて蛋白質Aの結合ドメインに対して弱い親和性を有するかまたは親和性を有し ていない抗体(2)を生産し、この場合、抗体(2)は、サブクラスIgG1、 IgG2a、IgG2b、IgG3のラット抗体またはサブクラスIgG3のヒ ト抗体もしくはヒト化された抗体であるようなハイブリドーマから融合されたク アドロームの製造、 b)常法でのクアドロームの増殖および培養、 c)蛋白質Aの結合ドメインを官能基として含有する材料で被覆されたカラム上 へのクアドローム培養上清の装填、 d)相応するpH範囲内での結合していない蛋白質の洗浄除去および e)蛋白質Aの結合ドメインに対してより強力な親和性を有する抗体がなお結合 しているpHを少なくとも 0.5単位上回っているpH範囲内でのbsAkの溶離 からなることを特徴とする、異種二重特異性抗体の製造法。 2.マウス抗体がサブクラスIgG2a、IgG2bまたはIgG3の抗体で ある、請求項1に記載の方法。 3.異種bsAkが、サブクラスIgG2bのラット抗体と融合したサブクラ スIgG2aのマウス抗体からなる、請求項1または2に記載の方法。 4.異種bsAkが、サブクラスIgG3のヒト抗体またはヒト化された抗体 と融合したサブクラスIgG1のヒト抗体またはヒト化された抗体からなる、請 求項1または2に記載の方法。 5.異種bsAkが、サブクラスIgG2bのラット抗体と融合したサブクラ スIgG2cのラット抗体からなる、請求項1または2に記載の方法。 6.異種bsAkが、サブクラスIgG1、IgG2a、IgG2bまたはI gG3のラット抗体と融合したサブクラスIgG1のヒト抗体またはヒト化した 抗体からなる、請求項1または2に記載の方法。 7.異種bsAkが、サブクラスIgG3のヒト抗体またはヒト化した抗体と 融合したサブクラスIgG2cラット抗体からなる、請求項1または2に記載の 方法。 8.異種bsAkが、サブクラスcIgG3のヒト抗体またはヒト化した抗体 と融合したサブクラスIgG2a、IgG2b、IgG3のマウス抗体からなる 、請求項1または2に記載の方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419399A DE4419399C1 (de) | 1994-06-03 | 1994-06-03 | Verfahren zur Herstellung von heterologen bispezifischen Antikörpern |
PE4419399.8 | 1994-06-03 | ||
DE4419399.8 | 1994-06-03 | ||
PCT/EP1995/001850 WO1995033844A1 (de) | 1994-06-03 | 1995-05-16 | Verfahren zur herstellung von heterologen bispezifischen antikörpern |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09506001A true JPH09506001A (ja) | 1997-06-17 |
JP3400457B2 JP3400457B2 (ja) | 2003-04-28 |
Family
ID=6519692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50022896A Expired - Lifetime JP3400457B2 (ja) | 1994-06-03 | 1995-05-16 | 異種二重特異性抗体の製造法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0763128B1 (ja) |
JP (1) | JP3400457B2 (ja) |
AT (1) | ATE187176T1 (ja) |
DE (3) | DE4419399C1 (ja) |
DK (1) | DK0763128T3 (ja) |
NL (1) | NL300419I1 (ja) |
WO (1) | WO1995033844A1 (ja) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007114325A1 (ja) * | 2006-03-31 | 2007-10-11 | Chugai Seiyaku Kabushiki Kaisha | 二重特異性抗体を精製するための抗体改変方法 |
WO2011078332A1 (ja) * | 2009-12-25 | 2011-06-30 | 中外製薬株式会社 | ポリペプチド多量体を精製するためのポリペプチドの改変方法 |
US8062635B2 (en) | 2003-10-10 | 2011-11-22 | Chugai Seiyaku Kabushiki Kaisha | Bispecific antibody substituting for functional proteins |
JP2012531439A (ja) * | 2009-06-26 | 2012-12-10 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
US8562991B2 (en) | 2008-09-26 | 2013-10-22 | Chugai Seiyaku Kabushiki Kaisha | Antibody molecules that bind to IL-6 receptor |
US8575317B2 (en) | 2007-12-05 | 2013-11-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-NR10 antibody and use thereof |
US8597911B2 (en) | 2003-06-11 | 2013-12-03 | Chugai Seiyaku Kabushiki Kaisha | Process for producing antibodies |
JP2014522644A (ja) * | 2011-07-07 | 2014-09-08 | サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク | 多重特異性抗体 |
US9096651B2 (en) | 2007-09-26 | 2015-08-04 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
US9228017B2 (en) | 2009-03-19 | 2016-01-05 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
US9334331B2 (en) | 2010-11-17 | 2016-05-10 | Chugai Seiyaku Kabushiki Kaisha | Bispecific antibodies |
US9688762B2 (en) | 2007-09-26 | 2017-06-27 | Chugai Sciyaku Kabushiki Kaisha | Modified antibody constant region |
US9868948B2 (en) | 2008-04-11 | 2018-01-16 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
US10011858B2 (en) | 2005-03-31 | 2018-07-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
US10150808B2 (en) | 2009-09-24 | 2018-12-11 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant regions |
US10253091B2 (en) | 2009-03-19 | 2019-04-09 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
US10435458B2 (en) | 2010-03-04 | 2019-10-08 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variants with reduced Fcgammar binding |
US10774148B2 (en) | 2015-02-27 | 2020-09-15 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating IL-6-related diseases |
US11046784B2 (en) | 2006-03-31 | 2021-06-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
US11066483B2 (en) | 2010-11-30 | 2021-07-20 | Chugai Seiyaku Kabushiki Kaisha | Cytotoxicity-inducing therapeutic agent |
US11124576B2 (en) | 2013-09-27 | 2021-09-21 | Chungai Seiyaku Kabushiki Kaisha | Method for producing polypeptide heteromultimer |
US11142587B2 (en) | 2015-04-01 | 2021-10-12 | Chugai Seiyaku Kabushiki Kaisha | Method for producing polypeptide hetero-oligomer |
US11649262B2 (en) | 2015-12-28 | 2023-05-16 | Chugai Seiyaku Kabushiki Kaisha | Method for promoting efficiency of purification of Fc region-containing polypeptide |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
US11891434B2 (en) | 2010-11-30 | 2024-02-06 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19634159C1 (de) * | 1996-08-23 | 1997-09-25 | Gsf Forschungszentrum Umwelt | Induktion einer Tumorimmunität durch Injektion von Hybridzellen |
DE19710497C2 (de) * | 1996-09-03 | 1998-07-09 | Gsf Forschungszentrum Umwelt | Verwendung Bi- und trispezifische Antikörper zur Induktion einer Tumorimmunität |
DE19649223C2 (de) * | 1996-09-03 | 1998-07-30 | Gsf Forschungszentrum Umwelt | Zerstörung von kontaminierenden Tumorzellen in Stammzelltransplantaten mit bispezifischen Antikörpern |
EP1820513A1 (en) | 2006-02-15 | 2007-08-22 | Trion Pharma Gmbh | Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
EP2241576A1 (en) | 2009-04-17 | 2010-10-20 | Trion Pharma Gmbh | Use of trifunctional bispecific antibodies for the treatment of tumors associated with CD133+/EpCAM+ cancer stem cells |
US8685524B2 (en) | 2010-01-29 | 2014-04-01 | Toray Industries, Inc. | Polylactic acid-based resin sheet |
US20130273055A1 (en) | 2010-11-16 | 2013-10-17 | Eric Borges | Agents and methods for treating diseases that correlate with bcma expression |
EP2524699A1 (en) | 2011-05-17 | 2012-11-21 | Trion Research GmbH | Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties |
US9750806B2 (en) | 2011-05-17 | 2017-09-05 | Trion Research Gmbh | Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties |
DK2728002T3 (da) | 2011-06-30 | 2022-04-04 | Chugai Pharmaceutical Co Ltd | Heterodimeriseret polypeptid |
EP2578230A1 (en) | 2011-10-04 | 2013-04-10 | Trion Pharma Gmbh | Removal of Tumor Cells from Intraoperative Autologous Blood Salvage |
US11142563B2 (en) | 2012-06-14 | 2021-10-12 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule containing modified Fc region |
MX371442B (es) | 2012-08-24 | 2020-01-30 | Chugai Pharmaceutical Co Ltd | VARIANTE DE LA REGION FC ESPECIFICA PARA FCyRIIB. |
IN2015MN00139A (ja) | 2012-09-25 | 2015-10-16 | Glenmark Pharmaceuticals Sa | |
WO2014104165A1 (ja) | 2012-12-27 | 2014-07-03 | 中外製薬株式会社 | ヘテロ二量化ポリペプチド |
SG11201603244VA (en) | 2013-11-04 | 2016-05-30 | Glenmark Pharmaceuticals Sa | Production of t cell retargeting hetero-dimeric immunoglobulins |
CN113278076A (zh) | 2013-11-11 | 2021-08-20 | 中外制药株式会社 | 含有改变了抗体可变区的抗原结合分子 |
US11773166B2 (en) | 2014-11-04 | 2023-10-03 | Ichnos Sciences SA | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production |
US11649293B2 (en) | 2015-11-18 | 2023-05-16 | Chugai Seiyaku Kabushiki Kaisha | Method for enhancing humoral immune response |
JP6931329B2 (ja) | 2015-11-18 | 2021-09-01 | 中外製薬株式会社 | 免疫抑制機能を有する細胞に対するt細胞リダイレクト抗原結合分子を用いた併用療法 |
TW202214700A (zh) | 2016-03-14 | 2022-04-16 | 日商中外製藥股份有限公司 | 用於癌之治療的細胞傷害誘導治療劑 |
US11667713B2 (en) | 2017-12-28 | 2023-06-06 | Chugai Seiyaku Kabushiki Kaisha | Cytotoxicity-inducing therapeutic agent |
US20210261669A1 (en) | 2018-06-20 | 2021-08-26 | Chugai Seiyaku Kabushiki Kaisha | Method for activating immune response of target cell and composition therefor |
EP4023230A4 (en) | 2019-06-05 | 2023-11-15 | Chugai Seiyaku Kabushiki Kaisha | ANTIBODY CLEAVAGE SITE BINDING MOLECULE |
CN113950485A (zh) | 2019-07-10 | 2022-01-18 | 中外制药株式会社 | 密蛋白-6结合分子及其用途 |
CN114364415A (zh) | 2019-07-18 | 2022-04-15 | 林迪斯血液护理有限责任公司 | 用三功能抗体清除术中自体血液回收中的肿瘤细胞 |
JP7373588B2 (ja) | 2019-12-27 | 2023-11-02 | 中外製薬株式会社 | 抗ctla-4抗体およびその使用 |
CA3173519A1 (en) | 2020-03-31 | 2021-10-07 | Vishnu Priyanka Reddy CHICHILI | Method for producing multispecific antigen-binding molecules |
KR20230048059A (ko) | 2020-07-31 | 2023-04-10 | 추가이 세이야쿠 가부시키가이샤 | 키메라 수용체를 발현하는 세포를 포함하는 의약 조성물 |
JPWO2022044248A1 (ja) | 2020-08-28 | 2022-03-03 | ||
EP3991796A1 (en) | 2020-10-27 | 2022-05-04 | Lindis Blood Care GmbH | An ex vivo method for removal of tumor cells from intra-operatively salvaged blood |
CA3220353A1 (en) | 2021-06-25 | 2022-12-29 | Chugai Seiyaku Kabushiki Kaisha | Use of anti-ctla-4 antibody |
CN117616123A (zh) | 2021-06-25 | 2024-02-27 | 中外制药株式会社 | 抗ctla-4抗体 |
JP2024524527A (ja) | 2021-07-05 | 2024-07-05 | トリオン リサーチ ゲーエムベーハー | がん治療において神経疼痛の消失または軽減をもたらす腫瘍関連抗原に結合する多重特異性抗体 |
EP4116330A1 (en) | 2021-07-05 | 2023-01-11 | Trion Research GmbH | Multispecific antibodies with monovalent binding to tumor-associated antigens causing no or reduced nerve pain in the treatment of cancer |
JPWO2023053282A1 (ja) | 2021-09-29 | 2023-04-06 | ||
JPWO2023058723A1 (ja) | 2021-10-08 | 2023-04-13 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8626413D0 (en) * | 1986-11-05 | 1986-12-03 | Gilliland L K | Antibodies |
GB8626412D0 (en) * | 1986-11-05 | 1986-12-03 | Clark M R | Antibodies |
-
1994
- 1994-06-03 DE DE4419399A patent/DE4419399C1/de not_active Expired - Lifetime
- 1994-06-03 DE DE122009000068C patent/DE122009000068I2/de active Active
-
1995
- 1995-05-16 DK DK95919458T patent/DK0763128T3/da active
- 1995-05-16 DE DE59507342T patent/DE59507342D1/de not_active Expired - Lifetime
- 1995-05-16 AT AT95919458T patent/ATE187176T1/de active
- 1995-05-16 WO PCT/EP1995/001850 patent/WO1995033844A1/de active IP Right Grant
- 1995-05-16 JP JP50022896A patent/JP3400457B2/ja not_active Expired - Lifetime
- 1995-05-16 EP EP95919458A patent/EP0763128B1/de not_active Expired - Lifetime
-
2009
- 2009-10-20 NL NL300419C patent/NL300419I1/nl unknown
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8597911B2 (en) | 2003-06-11 | 2013-12-03 | Chugai Seiyaku Kabushiki Kaisha | Process for producing antibodies |
US8062635B2 (en) | 2003-10-10 | 2011-11-22 | Chugai Seiyaku Kabushiki Kaisha | Bispecific antibody substituting for functional proteins |
US11168344B2 (en) | 2005-03-31 | 2021-11-09 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
US10011858B2 (en) | 2005-03-31 | 2018-07-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
US11046784B2 (en) | 2006-03-31 | 2021-06-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
US9670269B2 (en) | 2006-03-31 | 2017-06-06 | Chugai Seiyaku Kabushiki Kaisha | Methods of modifying antibodies for purification of bispecific antibodies |
JP5144499B2 (ja) * | 2006-03-31 | 2013-02-13 | 中外製薬株式会社 | 二重特異性抗体を精製するための抗体改変方法 |
WO2007114325A1 (ja) * | 2006-03-31 | 2007-10-11 | Chugai Seiyaku Kabushiki Kaisha | 二重特異性抗体を精製するための抗体改変方法 |
US10934344B2 (en) | 2006-03-31 | 2021-03-02 | Chugai Seiyaku Kabushiki Kaisha | Methods of modifying antibodies for purification of bispecific antibodies |
US11332533B2 (en) | 2007-09-26 | 2022-05-17 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant region |
US11248053B2 (en) | 2007-09-26 | 2022-02-15 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
US9096651B2 (en) | 2007-09-26 | 2015-08-04 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
US9828429B2 (en) | 2007-09-26 | 2017-11-28 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
US9688762B2 (en) | 2007-09-26 | 2017-06-27 | Chugai Sciyaku Kabushiki Kaisha | Modified antibody constant region |
US9399680B2 (en) | 2007-12-05 | 2016-07-26 | Chugai Seiyaku Kabushiki Kaisha | Nucleic acids encoding anti-NR10 antibodies |
US8575317B2 (en) | 2007-12-05 | 2013-11-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-NR10 antibody and use thereof |
US10472623B2 (en) | 2008-04-11 | 2019-11-12 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding two or more antigen molecules repeatedly |
US11371039B2 (en) | 2008-04-11 | 2022-06-28 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
US11359194B2 (en) | 2008-04-11 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding two or more antigen molecules repeatedly |
US9868948B2 (en) | 2008-04-11 | 2018-01-16 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
US9890377B2 (en) | 2008-04-11 | 2018-02-13 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
US8562991B2 (en) | 2008-09-26 | 2013-10-22 | Chugai Seiyaku Kabushiki Kaisha | Antibody molecules that bind to IL-6 receptor |
US10662245B2 (en) | 2008-09-26 | 2020-05-26 | Chugai Seiyaku Kabushiki Kaisha | Methods of reducing IL-6 activity for disease treatment |
US9228017B2 (en) | 2009-03-19 | 2016-01-05 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
US10066018B2 (en) | 2009-03-19 | 2018-09-04 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
US10253091B2 (en) | 2009-03-19 | 2019-04-09 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
JP2012531439A (ja) * | 2009-06-26 | 2012-12-10 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
JP2015227386A (ja) * | 2009-06-26 | 2015-12-17 | リジェネロン・ファーマシューティカルズ・インコーポレ | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
JP2021004261A (ja) * | 2009-06-26 | 2021-01-14 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
US10150808B2 (en) | 2009-09-24 | 2018-12-11 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant regions |
JP6087054B2 (ja) * | 2009-12-25 | 2017-03-01 | 中外製薬株式会社 | ポリペプチド多量体を精製するためのポリペプチドの改変方法 |
AU2010336277B2 (en) * | 2009-12-25 | 2015-02-19 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide modification method for purifying polypeptide multimers |
WO2011078332A1 (ja) * | 2009-12-25 | 2011-06-30 | 中外製薬株式会社 | ポリペプチド多量体を精製するためのポリペプチドの改変方法 |
JPWO2011078332A1 (ja) * | 2009-12-25 | 2013-05-09 | 中外製薬株式会社 | ポリペプチド多量体を精製するためのポリペプチドの改変方法 |
US10435458B2 (en) | 2010-03-04 | 2019-10-08 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variants with reduced Fcgammar binding |
US10450381B2 (en) | 2010-11-17 | 2019-10-22 | Chugai Seiyaku Kabushiki Kaisha | Methods of treatment that include the administration of bispecific antibodies |
US9334331B2 (en) | 2010-11-17 | 2016-05-10 | Chugai Seiyaku Kabushiki Kaisha | Bispecific antibodies |
US11066483B2 (en) | 2010-11-30 | 2021-07-20 | Chugai Seiyaku Kabushiki Kaisha | Cytotoxicity-inducing therapeutic agent |
US11891434B2 (en) | 2010-11-30 | 2024-02-06 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
JP2014522644A (ja) * | 2011-07-07 | 2014-09-08 | サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク | 多重特異性抗体 |
US11124576B2 (en) | 2013-09-27 | 2021-09-21 | Chungai Seiyaku Kabushiki Kaisha | Method for producing polypeptide heteromultimer |
US10774148B2 (en) | 2015-02-27 | 2020-09-15 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating IL-6-related diseases |
US11142587B2 (en) | 2015-04-01 | 2021-10-12 | Chugai Seiyaku Kabushiki Kaisha | Method for producing polypeptide hetero-oligomer |
US11649262B2 (en) | 2015-12-28 | 2023-05-16 | Chugai Seiyaku Kabushiki Kaisha | Method for promoting efficiency of purification of Fc region-containing polypeptide |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
Also Published As
Publication number | Publication date |
---|---|
DK0763128T3 (da) | 2000-04-10 |
JP3400457B2 (ja) | 2003-04-28 |
DE122009000068I1 (de) | 2010-05-27 |
EP0763128A1 (de) | 1997-03-19 |
DE4419399C1 (de) | 1995-03-09 |
DE122009000068I2 (de) | 2011-06-16 |
NL300419I1 (nl) | 2010-01-04 |
EP0763128B1 (de) | 1999-12-01 |
DE59507342D1 (de) | 2000-01-05 |
ATE187176T1 (de) | 1999-12-15 |
WO1995033844A1 (de) | 1995-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09506001A (ja) | 異種二重特異性抗体の製造法 | |
US5945311A (en) | Method for producing heterologous bi-specific antibodies | |
AU2017221794B2 (en) | Methods of Purifying Antibodies | |
Wong et al. | Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. | |
CN104039808B (zh) | 用bis-tris缓冲液的蛋白纯化 | |
JP2001504838A (ja) | タンパク質精製 | |
TW200840821A (en) | Methods of purifying anti A beta antibodies | |
JP6009431B2 (ja) | アフィニティー精製の方法 | |
Curling | The development of antibody purification technologies | |
CN111491951A (zh) | 通过疏水相互作用色谱法耗尽轻链错配的抗体变体 | |
CA3072129A1 (en) | Method for purifying proteins | |
JPH06102680B2 (ja) | F VIII/vWF複合体吸着のための免疫吸着材 | |
JP2023523823A (ja) | タンパク質の精製の改善されたプロセス | |
US11964998B2 (en) | Method for purifying anti-IL-6 receptor antibodies | |
TSO et al. | Preparation of a Bispecific F (ab') 2 Targeted to the Human IL-2 Receptor | |
Gupta et al. | Affinity chromatography and co-chromatography of bispecific monoclonal antibody immunoconjugates | |
JP2560069B2 (ja) | エリスロポエチンの製造方法 | |
JP3255640B2 (ja) | 抗体の分離法 | |
JP3007672B2 (ja) | 抗crpモノクローナル抗体、ハイブリドーマ、およびヒトcrpの回収精製方法 | |
Bazin et al. | Purification of Mouse Monoclonal Antibodies by Immunoaffinity Chromatography | |
JP3858945B2 (ja) | ハイブリドーマの選抜方法 | |
CN117126227A (zh) | 表面活性剂在疏水层析纯化蛋白中提高回收率的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080221 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090221 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100221 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100221 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110221 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120221 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130221 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140221 Year of fee payment: 11 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |